Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Demyelinating Autoimmune Diseases, Central Nervous System (CNS)”

621 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 621 results

Testing effectiveness (Phase 2)Looking for participantsNCT06890923
What this trial is testing

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD 55
Not applicableUnknownNCT04762342
What this trial is testing

Power Training in Older Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisSclerosisDemyelinating Autoimmune Diseases, CNS+4 more
University of Aarhus 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Not applicableUnknownNCT05496881
What this trial is testing

Exercise Effects in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive+2 more
University of Regina 69
Testing effectiveness (Phase 2)Ended earlyNCT01963611
What this trial is testing

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
EMD Serono 255
Large-scale testing (Phase 3)Study completedNCT00087529
What this trial is testing

Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Genentech, Inc. 439
Not applicableActive Not RecruitingNCT04564495
What this trial is testing

Home Based Tele-exercise for People With Chronic Neurological Impairments

Who this might be right for
Neurologic DisorderStrokeSpinal Cord Injuries+8 more
Burke Medical Research Institute 60
Not applicableUnknownNCT01811290
What this trial is testing

A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Simnad, Virginia, M.D. 36
Large-scale testing (Phase 3)Study completedNCT00213135
What this trial is testing

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
EMD Serono 1,326
Testing effectiveness (Phase 2)Looking for participantsNCT05549258
What this trial is testing

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 15
Not applicableLooking for participantsNCT07738978
What this trial is testing

Understanding and Enhancing Human Health and Movement

Who this might be right for
Spinal Cord InjuryStroke (CVA) or Transient Ischemic AttackMultiple Sclerosis
Louis Stokes VA Medical Center 75
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableUnknownNCT06055998
What this trial is testing

Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

Who this might be right for
Transverse Myelitis
Assiut University 50
Not applicableStudy completedNCT05913219
What this trial is testing

Smart Wearable Device (gaitQ): Walk Better Project

Who this might be right for
Parkinson DiseaseStrokeMultiple Sclerosis+2 more
University of Exeter 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT06384976
What this trial is testing

KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis+1 more
Kyverna Therapeutics 120
Testing effectiveness (Phase 2)Study completedNCT01051817
What this trial is testing

POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

Who this might be right for
Relapsing-remitting Multiple SclerosisRRMS
Novartis Pharmaceuticals 73
Post-approval studies (Phase 4)Study completedNCT01236534
What this trial is testing

Lubiprostone in Patients With Multiple Sclerosis Associated Constipation

Who this might be right for
Multiple SclerosisConstipation
University of Rochester 21
Not applicableStudy completedNCT04969848
What this trial is testing

Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device

Who this might be right for
Multiple Sclerosis
Nantes University Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT07074886
What this trial is testing

Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 193
Not applicableUnknownNCT03839381
What this trial is testing

Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments

Who this might be right for
Parkinson DiseaseMultiple SclerosisTrauma, Brain
Ordu University 50
Next Page